These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 32573903)

  • 1. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
    Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
    Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
    Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
    Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
    Yin T; Li Y; Ying Y; Luo Z
    BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes increases the mortality of patients with COVID-19: a meta-analysis.
    Wu ZH; Tang Y; Cheng Q
    Acta Diabetol; 2021 Feb; 58(2):139-144. PubMed ID: 32583078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
    Bajgain KT; Badal S; Bajgain BB; Santana MJ
    Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of co-morbidities and its association with mortality in Indian patients with COVID-19: A meta-analysis.
    Jindal R; Gupta M; Khan FR; Chaudhry G
    Indian J Anaesth; 2022 Jun; 66(6):399-418. PubMed ID: 35903589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
    Dorjee K; Kim H; Bonomo E; Dolma R
    PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis.
    Khan MMA; Khan MN; Mustagir MG; Rana J; Islam MS; Kabir MI
    J Glob Health; 2020 Dec; 10(2):020503. PubMed ID: 33110586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India.
    Jayaswal SK; Singh S; Malik PS; Venigalla SK; Gupta P; Samaga SN; Hota RN; Bhatia SS; Gupta I
    Diabetes Metab Syndr; 2021; 15(5):102248. PubMed ID: 34412000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes, obesity and COVID-19: A complex interplay.
    Vas P; Hopkins D; Feher M; Rubino F; B Whyte M
    Diabetes Obes Metab; 2020 Oct; 22(10):1892-1896. PubMed ID: 32627299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis.
    Luo L; Fu M; Li Y; Hu S; Luo J; Chen Z; Yu J; Li W; Dong R; Yang Y; Tu L; Xu X
    Clin Cardiol; 2020 Dec; 43(12):1478-1493. PubMed ID: 33026120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Centrality of Obesity in the Course of Severe COVID-19.
    Liu D; Zhang T; Wang Y; Xia L
    Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of severe COVID-19: A systematic review and meta-analysis.
    Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D
    Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis.
    Schlesinger S; Neuenschwander M; Lang A; Pafili K; Kuss O; Herder C; Roden M
    Diabetologia; 2021 Jul; 64(7):1480-1491. PubMed ID: 33907860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis.
    Ssentongo P; Ssentongo AE; Heilbrunn ES; Ba DM; Chinchilli VM
    PLoS One; 2020; 15(8):e0238215. PubMed ID: 32845926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
    Shin EK; Choi HY; Hayes N
    Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City.
    Park BE; Lee JH; Park HK; Kim HN; Jang SY; Bae MH; Yang DH; Park HS; Cho Y; Lee BY; Nam CW; Lee JB; Kim U; Chae SC;
    J Korean Med Sci; 2021 Jan; 36(2):e15. PubMed ID: 33429474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between chronic kidney disease and COVID-19-related mortality in New York.
    Mohamed NE; Benn EKT; Astha V; Okhawere KE; Korn TG; Nkemdirim W; Rambhia A; Ige OA; Funchess H; Mihalopoulos M; Meilika KN; Kyprianou N; Badani KK
    World J Urol; 2021 Aug; 39(8):2987-2993. PubMed ID: 33481113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA.
    ;
    Nephrol Dial Transplant; 2021 Jan; 36(1):87-94. PubMed ID: 33340043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.